Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 24, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 26, 2026
OfficerGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001644207-26-000002
Filed / recorded
Feb 26, 2026, 11:35 PM UTC
Added to OQRO
Oct 2, 2026, 12:26 PM UTC
Parser
form4-xml-v1
Data quality
Verified: identifiers matched exactly
Issuer
ABBOTT LABORATORIES
Issuer CIK
1800
Ticker
ABT
Reporting person
John A. Jr. Mccoy
Relationship
Officer
Officer title
VICE PRESIDENT AND CONTROLLER
Security
Common shares without par value
Table
Non-derivative (Table I)
Transaction date
Feb 24, 2026
Transaction code
A
Shares / units
5,373
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
26,355
Ownership form
Direct
Amendment
No
Footnotes from the filing
These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.